Psoriatic Arthritis News

Among health care professionals, discomfort can be the mother of invention, to coin a phrase. Rheumatologists have long voiced uncertainty about managing the dermatologic manifestations of rheumatoid arthritis, psoriatic arthritis, scleroderma and systemic lupus erythematosus, among other conditions. Conversely, dermatologists presented with a patient who exhibits topical signs of an underlying rheumatic or autoimmune condition have been confounded by treatment and management options. The discomfort runs both ways.

Intravenous golimumab, in doses of 2 mg per kg, reduced the signs and symptoms of psoriatic arthritis through1 year, with improvements in health-related quality of life maintained throughout that time, according to findings published in Arthritis Care & Research.

DESTIN, Fla. — Despite a recent explosion of new and emerging medications, patients with psoriatic arthritis still have many unmet needs, including more personalized treatment and control over immunogenicity, according to Philip J. Mease, MD, of the University of Washington.

DESTIN, Fla. — Despite its common association with autoimmune diseases, just 17% of patients with uveitis are evaluated for, or diagnosed with, a systemic autoimmune disease when receiving ophthalmology care, according to a presenter at the 2019 North American Young Rheumatology Investigator Forum.

Psoriatic arthritis and psoriasis severely disrupt patients’ ability to function day-to-day as well as their psycholsocial well-being, with many patients carrying unmet expectations regarding treatment efficacy, according to recent findings in Arthritis Care & Research.

More than 620 registered attendees from 45 states and 11 countries are traveling to Destin, Florida, this week for the 2019 Congress of Clinical Rheumatology, scheduled for May 2 to 5, according to David McLain, MD, FACP, FACR, where they will learn about a wide range of topics from speakers they may not hear anywhere else.

Sexual dysfunction is highly prevalent among men and women with inflammatory arthritis, with diseases-related factors impacting fluctuations in sexual function and reduced sexual desire, according to data published in Arthritis Care & Research.

The FDA has approved the second biosimilar to etanercept, etanercept-ykro, for all eligible indications of the biologic product, according to an FDA press release.

Enthesitis is common among patients with psoriatic arthritis and psoriasis, as well as individuals with fibromyalgia who undergo a clinical examination only, according to findings published in the Journal of Rheumatology.

CHICAGO — Although rheumatologists have enjoyed an improved understanding of the pathogenesis of psoriatic arthritis, none of the newer drugs have proved superior to traditional therapies, according to Elaine Husni, MD, MPH, of the Cleveland Clinic.